Consultants portal
DCVMN is neither responsible nor liable for any statement made by the consultants listed in this database, nor for their past or future performance of work.
| Area1 | Area2 | Area3 | Area4 | Area5 | Country | Name | Action |
|---|---|---|---|---|---|---|---|
| Marketing | Marketing | Fundraising and International Financing Expertise | Fundraising and International Financing Expertise | Governance and Ethics | France | Miloud Kaddar | Log in to see the file (Members only) |
| Technologies | Technologies | Preclinical assays | Technologies | Clinical trials design | United States | Florian Schodel | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Argentina | Victor Maqueda | Log in to see the file (Members only) |
| Premises design, qualification and validation | Technologies | Technologies | Premises design, qualification and validation | Clinical trials design | Australia | David Buckley | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Technologies | India | Paramdeep Singh | Log in to see the file (Members only) |
| Technologies | Technologies | Preclinical assays | Preclinical assays | Premises design, qualification and validation | Belgium | Nicolas Havelange | Log in to see the file (Members only) |
| Technologies | Technologies | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | India | Anil Chawla | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Clinical trials design | Premises design, qualification and validation | Premises design, qualification and validation | Netherlands | Jaap Koster | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Governance and Ethics | Australia | Stephen Williams | Log in to see the file (Members only) |
| Clinical trials design | Clinical trials design | Clinical trials design | Premises design, qualification and validation | Fundraising and International Financing Expertise | Italy | Simonetta Viviani | Log in to see the file (Members only) |
| Marketing | Fundraising and International Financing Expertise | Marketing | Fundraising and International Financing Expertise | Fundraising and International Financing Expertise | United States | Elizabeth Gardiner | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Technologies | Premises design, qualification and validation | Technologies | United States | Thomas Ransohoff | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Canada | Liliana Chocarro | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Preclinical assays | Technologies | Preclinical assays | United States | John Hennessey, Jr. | Log in to see the file (Members only) |
| Premises design, qualification and validation | Technologies | Technologies | United States | Barry Rosenblatt | Log in to see the file (Members only) | ||
| Premises design, qualification and validation | Premises design, qualification and validation | Thailand | Alain Kupferman | Log in to see the file (Members only) | |||
| Technologies | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Germany | Ute Krahl | Log in to see the file (Members only) | |
| Technologies | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Brazil | Aldrey Oliveira | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | India | Vibin Joseph | Log in to see the file (Members only) |
| Marketing | Marketing | Marketing | Fundraising and International Financing Expertise | Fundraising and International Financing Expertise | United States | Kevin O'Neill | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | New Zealand | Maurice Parlane | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Argentina | Sandra Rumiano | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | South Africa | Maureen Dennehy | Log in to see the file (Members only) | |
| Technologies | Technologies | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | INDIA | JAINENDRA JAIN | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Preclinical assays | USA | Rajesh Gupta | Log in to see the file (Members only) |
| Marketing | Marketing | Marketing | Mexico | Sonia Villasenor | Log in to see the file (Members only) | ||
| Technologies | Technologies | Technologies | Technologies | Premises design, qualification and validation | India | Lajpat Sood | Log in to see the file (Members only) |
| Technologies | Preclinical assays | Preclinical assays | Switzerland | Nora Dellepiane | Log in to see the file (Members only) | ||
| Clinical trials design | Clinical trials design | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | France | Marie-Françoise SCHERRER-MAKADI | Log in to see the file (Members only) |
| Preclinical assays | Preclinical assays | Preclinical assays | Technologies | Technologies | Thailand | Rochapon Wacharotayankun | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Italy | Dario Cresci | Log in to see the file (Members only) | ||
| Premises design, qualification and validation | Premises design, qualification and validation | Marketing | The Netherlands | Philip Beek | Log in to see the file (Members only) | ||
| Premises design, qualification and validation | Premises design, qualification and validation | Singapore | Paul Huntly | Log in to see the file (Members only) | |||
| Technologies | Technologies | Premises design, qualification and validation | Preclinical assays | Technologies | Belgium | Jean Smal | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Technologies | Technologies | Premises design, qualification and validation | Switzerland | Alain Pralong | Log in to see the file (Members only) |
| Clinical trials design | Belgium | Andrea Lohee | Log in to see the file (Members only) | ||||
| Premises design, qualification and validation | Premises design, qualification and validation | Marketing | Premises design, qualification and validation | Marketing | South Africa | Allan Thomas | Log in to see the file (Members only) |
| Clinical trials design | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Belgium | Pieter NEELS | Log in to see the file (Members only) | |
| Technologies | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Technologies | India | Ganesh Kumraj | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Technologies | Italy | Aldo Giannozzi | Log in to see the file (Members only) | ||
| Marketing | Marketing | Governance and Ethics | Governance and Ethics | USA | Mark Paxton | Log in to see the file (Members only) | |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Belgium | Toon De Kesel | Log in to see the file (Members only) | |
| Fundraising and International Financing Expertise | Marketing | Governance and Ethics | switzerland | ilaria cameli | Log in to see the file (Members only) | ||
| Governance and Ethics | Premises design, qualification and validation | Fundraising and International Financing Expertise | Premises design, qualification and validation | Fundraising and International Financing Expertise | The Netherlands | Jan Hendriks | Log in to see the file (Members only) |
| Technologies | Technologies | USA | Rebecca Sheets | Log in to see the file (Members only) | |||
| Premises design, qualification and validation | Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | The Netherlands | ian sykes | Log in to see the file (Members only) |
| Technologies | Preclinical assays | Clinical trials design | Premises design, qualification and validation | Premises design, qualification and validation | Chian | Allen Goldenthal | Log in to see the file (Members only) |
| Preclinical assays | Technologies | Technologies | Technologies | Premises design, qualification and validation | France | Jean CHAPSAL | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Marketing | Premises design, qualification and validation | Turkey | Mustafa Edik | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Preclinical assays | Premises design, qualification and validation | Switzerland | Drew Meek | Log in to see the file (Members only) |
| Fundraising and International Financing Expertise | Fundraising and International Financing Expertise | Marketing | Fundraising and International Financing Expertise | USA | Stephen Jarrett | Log in to see the file (Members only) | |
| Clinical trials design | Clinical trials design | Clinical trials design | Clinical trials design | Premises design, qualification and validation | Switzerland | Katharina Hartmann | Log in to see the file (Members only) |
| Marketing | Marketing | Marketing | Marketing | Governance and Ethics | india | Ashish Agarwal | Log in to see the file (Members only) |
| Technologies | Technologies | Technologies | Preclinical assays | Preclinical assays | USA | Viliam Pavliak | Log in to see the file (Members only) |
| Governance and Ethics | Preclinical assays | Fundraising and International Financing Expertise | Switzerland | Laura Viviani | Log in to see the file (Members only) | ||
| Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | France | Philippe Robin | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Clinical trials design | Egypt | Mona Salem | Log in to see the file (Members only) | ||
| Marketing | Fundraising and International Financing Expertise | Marketing | Fundraising and International Financing Expertise | Marketing | India | Ganesh R | Log in to see the file (Members only) |
| Preclinical assays | United States | Stanley Deming | Log in to see the file (Members only) | ||||
| Preclinical assays | Preclinical assays | Clinical trials design | Premises design, qualification and validation | Netherlands | Coenraad Hendriksen | Log in to see the file (Members only) | |
| Technologies | Technologies | Technologies | Preclinical assays | Preclinical assays | United States | Juan Arciniega | Log in to see the file (Members only) |
| Marketing | Marketing | Technologies | Technologies | Governance and Ethics | China | Ke Wu | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Technologies | INDIA | SUBRAHMANYAM MANTHA | Log in to see the file (Members only) | ||
| Fundraising and International Financing Expertise | Marketing | Fundraising and International Financing Expertise | USA | Jennifer Woolley | Log in to see the file (Members only) | ||
| Technologies | Fundraising and International Financing Expertise | Premises design, qualification and validation | Governance and Ethics | Marketing | United States | Shanda Boyle | Log in to see the file (Members only) |
| Technologies | Premises design, qualification and validation | Premises design, qualification and validation | Technologies | Premises design, qualification and validation | India | Davender Kumar Bhati | Log in to see the file (Members only) |
| Fundraising and International Financing Expertise | Premises design, qualification and validation | Marketing | Marketing | Governance and Ethics | France | Laurent Arnould | Log in to see the file (Members only) |
| Technologies | Technologies | Preclinical assays | Preclinical assays | Premises design, qualification and validation | United States | Timothy Schofield | Log in to see the file (Members only) |
| Clinical trials design | Clinical trials design | Clinical trials design | Clinical trials design | Belgium | Paul Willems | Log in to see the file (Members only) | |
| Clinical trials design | Premises design, qualification and validation | Clinical trials design | Belgium | Bernadette Hendrickx | Log in to see the file (Members only) | ||
| Clinical trials design | Clinical trials design | Technologies | Technologies | Marketing | United States of America | Paul Kilgore | Log in to see the file (Members only) |
| Premises design, qualification and validation | Clinical trials design | Clinical trials design | Clinical trials design | Premises design, qualification and validation | Belgium | Anne Hepburn | Log in to see the file (Members only) |
| Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Premises design, qualification and validation | Switzerland | Alessandra Seriacopi | Log in to see the file (Members only) | |
| Technologies | Preclinical assays | Premises design, qualification and validation | Premises design, qualification and validation | Technologies | Mexico | Juan Antonio Montaño Hirose | Log in to see the file (Members only) |
| Clinical trials design | Clinical trials design | Clinical trials design | Governance and Ethics | Kenya | Samuel Tesema | Log in to see the file (Members only) |
Sponsors:
